Carboxamide derivative and pharmaceutical composition for preventing or treating mental disease containing same as active ingredient

Disclosed are a carboxamide derivative and a pharmaceutical composition for preventing or treating mental diseases comprising the same as an active ingredient. The derivative is very effective as a triple reuptake inhibitor of serotonin, noradrenaline, and dopamine, and thus can be effectively used...

Full description

Saved in:
Bibliographic Details
Main Authors PARK DONG-HYUN, KIM YOUNG-EUN, KANG JI-HEE, SHIN CHAN-YOUNG, CHO KYU-SEOK, LIN CHUNYING, LEE EUN-HYE, CHOI YOO-JUNG, PARK GA-YOUNG, E. B. GAW, KWON KYONG-JA, KIM SOONG-HYUN, PARK YU-JIN, CHA EUN-JU, SONG MIN-SU, MARBANGA DAVID F, JEON SE-JIN, PODDER SANJAY, BAE SE-RI, HWANG HEE-JONG, SEO CHANG-HOON
Format Patent
LanguageChinese
English
Published 02.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are a carboxamide derivative and a pharmaceutical composition for preventing or treating mental diseases comprising the same as an active ingredient. The derivative is very effective as a triple reuptake inhibitor of serotonin, noradrenaline, and dopamine, and thus can be effectively used in the treatment of mental diseases. 本发明公开了甲酰胺衍生物和包含其作为活性成分的用于预防或治疗精神疾病的药物组合物。该衍生物作为血清素、去甲肾上腺素和多巴胺的三重再摄取抑制剂非常有效,因此可有效用于治疗精神疾病。
Bibliography:Application Number: CN202180058701